Advanced company searchLink opens in new window

GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED

Company number 04173789

Persons with significant control: 2 persons with significant control / 0 statements

Mr Anthony Rowlands

Correspondence address
Rsm Restructuring Advisory Llp, 3 Hardman Street, Manchester, M3 3HF
Notified on
20 January 2017
Date of birth
June 1956
Nationality
British
Country of residence
Monaco
Nature of control
Has significant influence or control

Bank Of New York (Nominees) Limited

Correspondence address
160 Queen Victoria Street, London, England, EC4V 4LA
Notified on
6 April 2016
Governing law
Legal form
Place registered
Companies House
Registration number
00928736
Incorporated in
England & Wales
Nature of control
Ownership of shares – More than 25% but not more than 50%
Ownership of voting rights - More than 25% but not more than 50%
Right to appoint or remove directors